Delivery Order SPE2DB25D3504-SPE2DB25FVVEC
- Not listed
- The Defense Logistics Agency awarded a $7,437.53 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Dupixent 300 mg/2 ml syringes. This non-competitive, competitively awarded delivery order is scheduled for completion by September 3, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract vehicle...
- The Defense Logistics Agency awarded a $17,566.90 delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL syringes on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed price delivery order represents a non-set-aside competitive award supporting the federal medical supply chain. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for the Department of Defense and...
- The Defense Logistics Agency awarded a $23,316.24 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Dupixent 300 mg/2 mL syringes. This non-competitive, firm fixed-price contract is scheduled for completion by September 9, 2025, with performance at the contractor's location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive...
- The Defense Logistics Agency has awarded a delivery order valued at $26,313.07 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml syringes. This is a firm fixed price, competitively awarded delivery order with an ultimate completion date of September 11, 2025. The contract does not include a set-aside designation. Performance will be executed from the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a $5,591.47 delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Dupixent 300 mg/2 ml syringes. This non-competitive delivery order represents a firm fixed-price contract with an ultimate completion date of August 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award falls under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $5,128.38 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL syringes on August 29, 2025, with an ultimate completion date of September 2, 2025. This non-competitive, competitively awarded firm fixed price delivery order was fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $26,943.08 delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Dupixent 300 mg/2 ml syringes. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 28, 2025. The pharmaceutical will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $20,513.52 to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL syringes on August 15, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside transaction for pharmaceutical supply to support federal medical procurement needs. The contract is executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $44,935.54 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml syringes on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a single-line procurement under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,957.42 to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Dupixent 300 mg/2 mL syringes. This non-competitive delivery order, with a firm fixed price structure, represents a child contract against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's...
- SPE2DB25D3504Indefinite Delivery Contract
- SPE2DB25D3504-SPE2DB25FVVECDelivery Order
The Defense Logistics Agency awarded a $21,126.84 delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of Dupixent 300 mg/2 ml syringes. This non-competitive delivery order represents a firm fixed price transaction with a completion deadline of June 23, 2025, and will be fulfilled at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, serves as the prime contractor on this order, which falls under the company's existing indefinite delivery contract vehicle with DLA Troop Support Medical. This delivery order is issued against AmerisourceBergen Drug Corp's SPE2DX indefinite delivery contract, a comprehensive $999.999 billion pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. The Dupixent delivery represents one of numerous small-to-medium value pharmaceutical orders the contractor fulfills for federal military and veteran healthcare systems through the DLA Medical Supply Chain, demonstrating the company's role as a key supplier within the Defense Health Agency's pharmaceutical procurement network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.1k | 6/20/25 |